Researchers at UC Irvine issue a warning that GLP-1RAs may be dangerous for children Source: UC Irvine School of Medicine Irvine, CA, August 28, 2023 A team of clinicians, exercise scientists, pharmaceutical scholars, ethicists and behavioral experts at the University of California, Irvine, outlined their concerns that the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) to treat childhood obesity and type 2 diabetes may have unintended and adverse consequences for childrens health
While these observations are anecdotal, they underline the need for more rigorous studies to shape the future of obesity management
For use by qualified professionals in a controlled laboratory environment only.
What Is a Fluoroscopy Injection? Wellness Blog, 2024
Greek Yogurt Protein is one of the strongest food signals for GLP-1